Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. - Chu X; Prasad B; Neuhoff S; Yoshida K; Leeder JS; Mukherjee D; Taskar K; Varma MVS; Zhang X; Yang X; Galetin A (Clinical pharmacology and therapeutics, 2022)